In 2019, Beijing E-Town International Investment & Development Co invested 200 million yuan in Shouyao Holdings in the form in the form of old-stock transfers and capital increases.

Headquartered in the Beijing Economic-Technological Development Area, Shouyao Holdings focuses on the development and production of new drugs to combat health issues such as tumors and diabetes.

By the beginning of 2020, the company had applied for 120 national invention patents, obtained 36 authorizations and 15 national first-class clinical approvals for new drugs, and won nine national ‘12th Five-Year Plan’ and ‘13th Five-Year Plan’ new drug creation projects.

Website: http://www.shouyaoholding.com/